Lung cancer is a leading cause of death in men and women, but until recently there has been little new to say in terms of diagnosis and treatment. This situation has changed with the arrival of - for instance - magnetic resonance imaging for more efficient diagnosis, and new treatment in the form of new surgical approaches, the use of lasers and adjuvant treatment (the boosting of the immune system). This volume concentrates on, and puts into perspective, the most recent and exciting advances, assuming basic knowledge of oncology and pulmonary and thoracic surgery.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
The best and most concise single source for state–of–the–art diagnosis and treatment of lung cancer newly revised, updated, and expanded.
Lung cancer has long been the number–one cause of death from cancer every year and the third most frequently diagnosed after breast and prostate cancers. In 2010, about 15% of all cancer diagnoses and 30% of all cancer deaths were due to lung cancer. Needless to say, there is a great need for more rapid advancements in diagnosis and treatment of this devastating disease.
Here is the comprehensively revised, updated, and expanded edition of the well–established, evidence–based reference book that deals with the most recent advances in lung cancer prevention, screening, diagnosis, research, and treatment for the clinician. Edited and authored by leading authorities in the field, this Fourth Edition of the highly regarded Lung Cancer is better than ever featuring nine new chapters along with seven re–formatted ones that are nearly brand new in content and approach. It covers Smoking Prevention and Cessation; Molecular Profiling; Somatic Genome Alterations in Human Lung Cancers; Management of Multi–Focal Bronchioloalveolar Carcinoma (BAC); Primary Tracheal Tumors; Predictive Tumor Biomarkers for EGFR Inhibitors; Non–Small Cell and Small–Cell Lung Carcinoma; and more.
This Fourth Edition of Lung Cancer:
With almost half of the revised and updated content being brand new, Lung Cancer, Fourth Edition, is an important and vital resource for all medical professionals and students involved in the care and treatment of those struck with this catastrophic illness.
Jack A. Roth, MD, F.A.C.S., is Professor and Bud Johnson Clinical Distinguished Chair in the Department of Thoracic and Cardiovascular Surgery, Professor of Molecular and Cellular Oncology, Director of the W.M. Keck Center of Innovative Cancer Therapies, and Chief of the Section of Thoracic Molecular Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, USA.
James D. Cox, MD, is Professor and Head of the Department of Radiation Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, USA.
Waun Ki Hong, MD, D.M.Sc. (Hon.), is the American Cancer Society Professor and Samsung Distinguished University Chair in Cancer Medicine, as well as Professor and Head of the Division of Cancer Medicine and Professor in the Department of Thoracic/Head and Neck Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, USA.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Better World Books Ltd, Dunfermline, Royaume-Uni
Etat : Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good. N° de réf. du vendeur 18497532-6
Quantité disponible : 1 disponible(s)
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
Hardcover. Etat : Like New. Like NewLIKE NEW. book. N° de réf. du vendeur ERICA83808654228263
Quantité disponible : 1 disponible(s)